US Stock MarketDetailed Quotes
MRNS Marinus Pharmaceuticals
- 1.410
- -0.030-2.08%
Close Apr 18 16:00 ET
- 1.380
- -0.030-2.13%
Post 18:13 ET
77.45MMarket Cap-536P/E (TTM)
1.530High1.170Low4.84MVolume1.460Open1.440Pre Close6.83MTurnover11.25%Turnover RatioLossP/E (Static)54.93MShares11.26052wk High4.62P/B60.62MFloat Cap1.11052wk Low--Dividend TTM42.99MShs Float82.880Historical High--Div YieldTTM25.00%Amplitude1.110Historical Low1.412Avg Price1Lot Size
About Marinus Pharmaceuticals Company
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.
Company Profile
SymbolMRNS
Company NameMarinus Pharmaceuticals
Listing DateJul 31, 2014
Issue Price8.00
Founded2003
CEODr. Scott Braunstein, M.D.
MarketNASDAQ
Employees165
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5 Radnor Corporate Center,100 Matsonford Road,Suite 500
CityRadnor
ProvincePennsylvania
CountryUnited States of America
Zip Code19087-5279
Phone1-484-801-4670
Websitehttp://www.marinuspharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Scott Braunstein, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 3.21M
- Christina Shafer
- Chief Commercial Officer
- --
- Steven Pfanstiel, C.M.A.,M.B.A.
- Chief Operating Officer, Chief Financial Officer and Treasurer
- 1.44M
- Joseph Hulihan
- Chief Medical Officer
- 1.37M
- Martha E. Manning, Esq.
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Dr. Sarah B. Noonberg, M.D.,PhD
- Director
- 315.20K
- Christine Berni Silverstein
- Independent Director
- 249.21K
- Timothy M. Mayleben
- Lead Independent Director
- 202.52K
- Elan Ezickson
- Independent Director
- 162.52K
- Seth H.Z. Fischer
- Independent Director
- 160.02K
- Marvin H. Johnson, Jr
- Independent Director
- 304.81K
- Charles Austin
- Independent Director
- 157.52K
- Dr. Saraswathy V. Nochur, PhD
- Independent Director
- 154.74K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
